Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Origins of the mutational origin of cancer.
Edler L, Kopp-Schneider A. Edler L, et al. Int J Epidemiol. 2005 Oct;34(5):1168-70. doi: 10.1093/ije/dyi134. Epub 2005 Jul 26. Int J Epidemiol. 2005. PMID: 16046521 No abstract available.
Statistical models for low dose exposure.
Edler L, Kopp-Schneider A. Edler L, et al. Mutat Res. 1998 Sep 20;405(2):227-36. doi: 10.1016/s0027-5107(98)00140-7. Mutat Res. 1998. PMID: 9748596
Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study.
Hartung G, Hofheinz RD, Dencausse Y, Sturm J, Kopp-Schneider A, Dietrich G, Fackler-Schwalbe I, Bornbusch D, Gonnermann M, Wojatschek C, Lindemann W, Eschenburg H, Jost K, Edler L, Hochhaus A, Queisser W. Hartung G, et al. Onkologie. 2005 Jun;28(6-7):347-50. doi: 10.1159/000084595. Epub 2005 Jun 2. Onkologie. 2005. PMID: 15933423 Clinical Trial.
"ToxRTool", a new tool to assess the reliability of toxicological data.
Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A, Hartung T, Hoffmann S. Schneider K, et al. Toxicol Lett. 2009 Sep 10;189(2):138-44. doi: 10.1016/j.toxlet.2009.05.013. Epub 2009 May 27. Toxicol Lett. 2009. PMID: 19477248
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial.
Ugurel S, Loquai C, Terheyden P, Schadendorf D, Richtig E, Utikal J, Gutzmer R, Rass K, Sunderkötter C, Stein A, Fluck M, Kaatz M, Trefzer U, Kähler K, Stadler R, Berking C, Höller C, Kerschke L, Edler L, Kopp-Schneider A, Becker JC. Ugurel S, et al. Oncotarget. 2017 Jun 27;8(44):76029-76043. doi: 10.18632/oncotarget.18635. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100289 Free PMC article.
Porphyrin studies in TCDD-exposed workers.
Jung D, Konietzko J, Reill-Konietzko G, Muttray A, Zimmermann-Hölz HJ, Doss M, Beck H, Edler L, Kopp-Schneider A. Jung D, et al. Arch Toxicol. 1994;68(9):595-8. doi: 10.1007/s002040050120. Arch Toxicol. 1994. PMID: 7998828
231 results